Rashes caused by arbidol in a patient with novel coronavirus pneumonia.
Adverse Drug Reactions Journal
; 22(6):373-374, 2020.
Article
in Chinese
| EMBASE | ID: covidwho-2305921
ABSTRACT
A 50-year-old male patient with agitated depression and hyperlipemia received oral amoxicillin and clavulanate potassium 0.5 g once daily and 2 lopinavir and ritonavir tablets twice daily for novel coronavirus infection, based on previous drugs including quetiapine, clonazepam, and atorvastatin calcium. After 3 days, lopinavir and ritonavir was changed to oral arbidol 200 mg, thrice daily due to suspicious drug interaction. After taking arbidol for 3 days, the patient developed red papules on the whole body. Considering that it might be related to amoxicillin and clavulanate potassium, the drug was stopped and loratadine was given. But the rashes were aggravated. Considering that the drug eruption was caused by arbidol, arbidol was discontinued and the rashes subsided in a large area the next day. Then vitamin C injection, calcium gluconate injection, and ribavirin were added. After 5 days, the rashes subsided completely. After 17 days, the patient recovered from pneumonia.Copyright © 2020 by the Chinese Medical Association.
Arbidol; Coronavirus infections; Novel coronavirus pneumonia; Skin rash; adult; agitated depression/dt [Drug Therapy]; antiviral therapy; article; case report; clinical article; coronavirus disease 2019/dt [Drug Therapy]; drug substitution; drug withdrawal; human; hyperlipidemia/dt [Drug Therapy]; male; middle aged; papule/dt [Drug Therapy]; papule/si [Side Effect]; priority journal; psychopharmacotherapy; rash/si [Side Effect]; amoxicillin plus clavulanic acid/po [Oral Drug Administration]; ascorbic acid/cb [Drug Combination]; ascorbic acid/dt [Drug Therapy]; atorvastatin/dt [Drug Therapy]; clonazepam/dt [Drug Therapy]; gluconate calcium/cb [Drug Combination]; gluconate calcium/dt [Drug Therapy]; lopinavir/cb [Drug Combination]; lopinavir/dt [Drug Therapy]; lopinavir/po [Oral Drug Administration]; loratadine/dt [Drug Therapy]; quetiapine/dt [Drug Therapy]; ribavirin/cb [Drug Combination]; ribavirin/dt [Drug Therapy]; ritonavir/cb [Drug Combination]; ritonavir/dt [Drug Therapy]; ritonavir/po [Oral Drug Administration]; umifenovir/ae [Adverse Drug Reaction]; umifenovir/dt [Drug Therapy]; umifenovir/po [Oral Drug Administration]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Chinese
Journal:
Adverse Drug Reactions Journal
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS